HeartFlow Overview
- Year Founded
-
2007

- Status
-
IPO Registration
- Employees
-
643

- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
29
HeartFlow General Information
Description
Developer of a cardiac diagnostic platform designed to transform the diagnosis and management of coronary artery diseases. The company's platform uses data from standard computerized tomography scans to create a personalized three-dimensional model of arteries and analyzes the impact of blockages on blood flow, enabling clinicians to treat patients with significant coronary artery disease while reducing unnecessary invasive testing.
Contact Information
Website
www.heartflow.comCorporate Office
- 331 East Evelyn Avenue
- Mountain View, CA 94041
- United States
Corporate Office
- 331 East Evelyn Avenue
- Mountain View, CA 94041
- United States
HeartFlow Timeline
HeartFlow Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
15. IPO | 19-Jan-2025 | Announced | Generating Revenue | |||
14. Later Stage VC | 11-Apr-2025 | Completed | Generating Revenue | |||
13. Later Stage VC (Series F) | 02-Mar-2023 | Completed | Generating Revenue | |||
12. Reverse Merger | 15-Jul-2021 | Cancelled | Generating Revenue | |||
11. Later Stage VC | 18-Dec-2019 | Completed | Generating Revenue | |||
10. Secondary Transaction - Private | 14-Jun-2019 | Completed | Generating Revenue | |||
9. Later Stage VC (Series E) | 13-Jun-2019 | Completed | Generating Revenue | |||
8. Later Stage VC (Series E) | 14-Feb-2018 | Completed | Generating Revenue | |||
7. Later Stage VC (Series D) | 10-May-2016 | $100M | $263M | Completed | Generating Revenue | |
6. Later Stage VC | 01-Feb-2015 | $35.9M | $163M | Completed | Generating Revenue |
HeartFlow Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B2 | ||||||||
Series B1 | 1,954,846 | $0.001000 | $0.28 | $3.55 | $3.55 | 1x | $3.55 | 3.16% |
Series A | 4,082,965 | $0.001000 | $0.03 | $0.5 | $0.5 | 1x | $0.5 | 6.61% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HeartFlow Comparisons
Industry
Financing
Details
HeartFlow Competitors (22)
One of HeartFlow’s 22 competitors is inHEART, a Private Equity-Backed company based in Pessac, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
inHEART | Private Equity-Backed | Pessac, France | ||||
Cleerly | Venture Capital-Backed | Denver, CO | ||||
Vista.ai | Venture Capital-Backed | Palo Alto, CA | ||||
Arterys | Formerly VC-backed | San Francisco, CA | ||||
Advantis Medical Imaging | Venture Capital-Backed | Eindhoven, Netherlands |
HeartFlow Patents
HeartFlow Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240387045-A1 | Systems and methods for processing electronic images to quantify coronary microvascualar disease | Pending | 17-May-2023 | ||
US-20230169702-A1 | Systems and methods for processing electronic images for physiology-compensated reconstruction | Pending | 29-Nov-2021 | ||
US-20230165544-A1 | Systems and methods for processing electronic images using user inputs | Pending | 29-Nov-2021 | ||
US-20220359063-A1 | Systems and methods for processing electronic images to determine a planar mapping | Pending | 05-May-2021 | ||
CA-3216802-A1 | Systems and methods for processing electronic images to determine a planar mapping | Pending | 05-May-2021 | G06T19/00 |
HeartFlow Signals
HeartFlow Investors (29)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Fidelity Management & Research Company | Asset Manager | |||
3Spoke Capital | Growth/Expansion | Majority | ||
Bain Capital Life Sciences | Corporate Venture Capital | Minority | ||
Hayfin Capital Management | Asset Manager | Minority | ||
Janus Henderson Investors | Asset Manager | Minority |
HeartFlow FAQs
-
When was HeartFlow founded?
HeartFlow was founded in 2007.
-
Where is HeartFlow headquartered?
HeartFlow is headquartered in Mountain View, CA.
-
What is the size of HeartFlow?
HeartFlow has 643 total employees.
-
What industry is HeartFlow in?
HeartFlow’s primary industry is Decision/Risk Analysis.
-
Is HeartFlow a private or public company?
HeartFlow is a Private company.
-
What is HeartFlow’s current revenue?
The current revenue for HeartFlow is
. -
How much funding has HeartFlow raised over time?
HeartFlow has raised $927M.
-
Who are HeartFlow’s investors?
Fidelity Management & Research Company, 3Spoke Capital, Bain Capital Life Sciences, Hayfin Capital Management, and Janus Henderson Investors are 5 of 29 investors who have invested in HeartFlow.
-
Who are HeartFlow’s competitors?
inHEART, Cleerly, Vista.ai, Arterys, and Advantis Medical Imaging are some of the 22 competitors of HeartFlow.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »